Morphinanverbindungen

Patent europeic · EP2792662 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2792662
Numer da la dumonda
EP14173190
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-04-2008
Publitgà
22-10-2014
Concedì
06-04-2016
Stritgà
30-04-2018
Motiv
Taxa annuala betg pajada
Classas IPC
C07B 59/00 (2006.01)
A61K 31/439 (2006.01)
A61P 11/14 (2006.01)
C07D 221/28 (2006.01)
Prioritad
US 915130 P 01.05.2007
US 916662 P 08.05.2007
US 976044 P 28.09.2007
Derivà da
EP11000764
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-11-2018

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.11.2018

  2. 28-06-2016

    Represchentant inscrit

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 28.06.2016

  3. 06-04-2016

    Concedì

    Published in Swissreg on 06.04.2016

Partidas

Possessur

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

99 Hayden Avenue, Lexington, MA 02421, US

Represchentant

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventur

Tung, Roger

Lexington, MA 02421, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.